Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note
— Canada’s Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up…
News
AIM ImmunoTech Provides Progress on Advancement of Ampligen® Clinical Development Program for the Treatment of Pancreatic Cancer
– Ampligen® (rintatolimod) has demonstrated promising activity as a potential maintenance therapy after systemic chemotherapy…
Achilles Therapeutics Announces Manufacturing Expansion in the UK and Partnership for Manufacturing in the US
– Expansion will supply clinical grade cNeT for ongoing Phase I/IIa clinical trials and support…
Harpoon Therapeutics Presents Preclinical Data for TriTAC-XR Platform that Supports Potential for Improved Safety by Minimizing Cytokine Release Syndrome
TriTAC-XR demonstrates extended release mechanism that confirms accumulation of active drug which improves therapeutic index…
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach
Presentations from multiple pipeline programs feature clinical and preclinical data demonstrating the unique biology of…
Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency and ENPP1 Deficiency
– First patient dosed in Phase 1/2 clinical trial in ABCC6 Deficiency – – Preliminary…
TOWER ONE SECURES CONTRACT TO BUILD SITES WITH TELEFONICA (ECUADOR)
Miami, Florida, April 12, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (OTCQB: TOWTF) (CSE:…
BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19
Phase I/II trial initiation expected in 3Q 2022 SUNNYVALE, Calif., April 12, 2022 (GLOBE NEWSWIRE)…
XORTX Receives No Objection Letter from Health Canada
Bridging Pharmacokinetics Study Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program CALGARY, Alberta, April 12, 2022…
Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia
-New Preclinical Data Highlight Fadraciclib’s Apoptosis Enabling Mechanism in Leukemia- -Remarkable Synergy Observed with Venetoclax,…
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery…
Arecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for Diabetes
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022 OF PHASE…
Tonix Pharmaceuticals to Participate in the NobleCon18 Investor Conference
CHATHAM, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
ALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board of Directors
Itziar Canamasas, Ph.D. ALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board of Directors SOUTH…
Clover To Present at World Vaccine Congress Washington 2022
SHANGHAI, China, April 12, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
FloQast Announces Account Reconciliation Management Solution To Increase Financial Close Velocity, Reduce Audit Burden, and Improve Accountants’ Work-Life Balance
Pairs new Reconciling Items feature with current capabilities, empowering accounting teams to manage account reconciliations…
Pax8 to Offer AWS Solutions Enabling MSPs to Build Secure Cloud Solutions
DENVER, April 12, 2022 (GLOBE NEWSWIRE) — Pax8, the best place for IT professionals to…
Elpha Secure launches cyber insurance offering on Socotra’s cloud-native platform in less than two months
Socotra’s flexible platform and open APIs empowered Elpha Secure to self-implement in record time AUSTIN,…
Fortinet Launches New Security Awareness and Training Service to Enhance Workforce Cyber Awareness and Mitigate Threats
John Maddison, EVP of Products and CMO at Fortinet“Fortinet is committed to keeping organizations secure…
Study: More Positive Results for People with Pre-dementia Conditions
SAN FRANCISCO, April 12, 2022 (GLOBE NEWSWIRE) — A new study suggests that cognitive decline…